PHVS416
Showing 1 - 3 of 3
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial (PHA-022121 low dose, PHA-022121 medium
Recruiting
- Hereditary Angioedema
- +11 more
- PHA-022121 low dose
- +3 more
-
Birmingham, Alabama
- +7 more
Dec 5, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +21 more
Aug 11, 2022
Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II Trial in Worldwide (PHA-022121, Placebo)
Active, not recruiting
- Hereditary Angioedema
- +9 more
- PHA-022121
- Placebo
-
Birmingham, Alabama
- +35 more
Aug 23, 2022